A61K 31/7076
Containing purines
Official title: containing purines, e.g. adenosine, adenylic acid
A61K31/7076 (Containing purines) appears on 1,705 US grants and 3,193 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,705
- Published applications
- 3,193
- Assignees
- 1,238
- Inventors
- 5,115
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 5 | 0 |
| 1997 | 30 | 0 |
| 1998 | 34 | 0 |
| 1999 | 27 | 0 |
| 2000 | 20 | 0 |
| 2001 | 26 | 11 |
| 2002 | 32 | 61 |
| 2003 | 33 | 94 |
| 2004 | 25 | 98 |
| 2005 | 20 | 105 |
| 2006 | 42 | 113 |
| 2007 | 32 | 103 |
| 2008 | 39 | 81 |
| 2009 | 37 | 108 |
| 2010 | 46 | 110 |
| 2011 | 48 | 119 |
| 2012 | 59 | 103 |
| 2013 | 67 | 135 |
| 2014 | 89 | 167 |
| 2015 | 78 | 148 |
| 2016 | 84 | 160 |
| 2017 | 89 | 126 |
| 2018 | 73 | 128 |
| 2019 | 99 | 167 |
| 2020 | 100 | 147 |
| 2021 | 94 | 181 |
| 2022 | 84 | 181 |
| 2023 | 78 | 169 |
| 2024 | 77 | 152 |
| 2025 | 69 | 133 |
| 2026 | 55 | 93 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- NiRAN interfering drugs for SARS-CoV-2 mutant therapy29 Sep 2026US 12,746,251 B2Atea Pharmaceuticals, Inc.
- Nootropic fullerenes and use22 Sep 2026US 12,741,033 B2Carbon 60 (Zhejiang) Pharmaceutical Technology Co., Ltd.
- Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus22 Sep 2026US 12,741,984 B2Atea Pharmaceuticals, Inc.
- Liposomes encapsulating adenosine15 Sep 2026US 12,734,129 B2New York University
- Prmt inhibitor compounds and the uses thereof8 Oct 2026US 2026/0306527 A1Purdue Research Foundation
- Indole lactate for the treatment of multiple sclerosis1 Oct 2026US 2026/0294870 A1The Johns Hopkins University
- Substituted bicyclic heterocycle compounds, compositions, and uses thereof1 Oct 2026US 2026/0294949 A1
- Bi- and monocyclic nucleoside analogs for treatment of hepatitis e1 Oct 2026US 2026/0294950 A1Janssen Pharmaceuticals, Inc.
- Compositions comprising fludarabine phosphate and methods of making and using same to treat cancer1 Oct 2026US 2026/0294951 A1Areva Pharmaceuitcals Limited
Most cited
By later US patents
- Maintenance of platelet inhibition during antiplatelet therapy253US 10,022,391 B2Chiesi Farmaceutici S.P. A. · 2018
- Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase223US 7,125,855 B2Merck & Co., Inc. · 2006
- Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus217US 6,777,395 B2Isis Pharmaceuticals, Inc. · 2004
- Prodrugs phosphorus-containing compounds200US 6,312,662 B1Metabasis Therapeutics, Inc. · 2001
- Adoptive cell therapy with young T cells191US 8,383,099 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2013